Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

100.24 -1.54 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
31 32 Next >
A Look Into Illumina's Debt
Via Benzinga
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
S&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slides
First Republic is the new bank in focus. Microsoft fell below a buy point. 
Via Investor's Business Daily
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
This Favorable Sign Appears On Illumina's Chart
Via Benzinga
RBC Capital Maintains Outperform Rating for Illumina: Here's What You Need To Know
Via Benzinga
The Latest Analyst Ratings for Illumina
Via Benzinga
Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
Why Illumina Shares Are Soaring Today?
Via Benzinga
ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies
Are you looking for the next trillion-dollar companies? Here are the stocks that ChatGPT thinks will help make you rich in the coming years. 
Via InvestorPlace
Icahn Reacts Audaciously To Illumina’s Audacity
Carl Icahn has correctly diagnosed what ails Illumina, but he is prescribing an overly aggressive treatment. The pushy billionaire wants three board seats at the biotechnology company, after it... 
Via Talk Markets
Universal Sequencing Technology Corporation Launches High-Throughput Solution For Microbial WGS Library Preparation
CARLSBAD, Calif. - March 14, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput... 
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Up 150 Points; Gold Rises Over 2%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded up 0.59% to 32,096.68 while the NASDAQ rose 1.35% to 11,288.8. The S&P... 
Via Benzinga
Stocks Rally As Investors Bet On Rate-Hike Pause
Wall Street is rallying midday, as investors muse over a potential pause to the Federal Reserve's interest rate hikes. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail
Icahn is reportedly planning a proxy fight with Illumina, frustrated by the Grail efforts. 
Via Investor's Business Daily
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
A Look Into Illumina's Debt
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
Why Is ROKU Stock Down Today?
Roku (ROKU) stock is taking a beating on Monday after it was revealed a large portion of the company's funds were held at Silicon Valley Bank. 
Via InvestorPlace
ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina
Illumina (ILMN) stock is a hot topic among traders on Monday as reports claim Carl Icahn is gearing up for a proxy fight. 
Via InvestorPlace
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis. 
Via Benzinga
Church & Dwight, A. O. Smith, Illumina And This US Bank Are CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said Church & Dwight Co., Inc. (NYSE: CHD) has consolidated the recent gains and is likely 
Via Benzinga
DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina
Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry 
From Myriad Genetics, Inc.
Via GlobeNewswire
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
Startling cancer vaccine results from Moderna may point to the next big thing in biotech. 
Via Investor's Business Daily
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),... 
Via SBWire
Topics Economy
Exposures Supply Chain
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,... 
Via SBWire
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.